Tag: Drug

A promising immune stimulating target- “OX40”

Articles

For over 100 years, immunotherapy has played a significant role in the treatment of cancer. Immune stimulatory agents such as Toll-like...

Read More

Anticoagulants (VTE & AF) Therapeutics Market is estimated to reach $17.2 billion by 2020

Anti-coagulants, Atrial Fibrillation, Business Consultant, CVS Indications, Uncategorized, Venous Thromboembolism

The Anticoagulants (VTE & AF) Therapeutics Market was around $11.4 billion in 2015 and is estimated to reach $17.2 billion by 2020...

Read More

Global VTE market is expected to grow to $4.75 billion by 2020 with a compound annual growth rate (CAGR) of 2.44%

Anti-coagulants, Business Consultant, Specialized Reports, Venous Thromboembolism

Venous Thromboembolism- Market Insights & Drugs Sales Forecast (VTE) -2020: New Report by DelveInsight suggests that the Global VTE...

Read More

Pancreatic Cancer – Market Insights, Epidemiology and Market Forecast-2020

Business Consultant, Pharma Consultant, Specialized Reports, Uncategorized

DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and...

Read More

Nonalcoholic Steatohepatitis (NASH) – Market Insights, Epidemiology and Market Forecast-2020

Pharma Consultant, Specialized Reports

DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and...

Read More

PD-1 and PD-L 1 inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016 -A DelveInsight Report

DelveInsight's Oncology based Reports, PD-1 and PD-L1 inhibitors, Pharma Consultant, Specialized Reports

DelveInsight has made strong presence in Oncology market with 100+ Reports on Oncology based Indications & Mechanism of Action...

Read More
Close